A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and risk (Q6976485)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 8048132
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and risk |
scientific article; zbMATH DE number 8048132 |
Statements
A mathematical model for maximizing the value of phase 3 drug development portfolios incorporating budget constraints and risk (English)
0 references
2 June 2025
0 references
phase 3 portfolio optimization
0 references
budget constraints
0 references
decision analysis
0 references
stochastic integer programming
0 references
risk
0 references
portfolio re-optimization
0 references
